Literature DB >> 9782315

Cytotoxic T lymphocyte responses to infectious bronchitis virus infection.

S H Seo1, E W Collisson.   

Abstract

Cytotoxic T lymphocyte (CTL) activity to infectious bronchitis virus (IBV) was examined at regular intervals between 3 and 30 days post infection (p.i.). The maximal CTL lysis of target cells infected with IBV with 82% was detected at 10 days p.i. The specific CTL activity began to decrease only after viral loads, which peaked at day 8 p.i. in both kidneys and lungs, started to decline. Therefore, the CTL response correlated with elimination of acute infection. IgM antibody did not appear until day 10 and levels peaked at day 12 p.i. whereas IgG antibody titers were detectable only by day 15 p.i., but continued to increase exponentially until day 30 p.i., the last day examined. IBV specific CTL epitope(s) were mapped within the carboxyl terminal 120 amino acids of nucleocapsid protein. In vivo inoculation of this fragment, as cDNA, induced protection against acute infection. The absence of viral neutralizing epitopes on the nucleocapsid protein would suggest that protection with known CTL eptiope(s) can be induced in the absence of neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9782315     DOI: 10.1007/978-1-4615-5331-1_58

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.

Authors:  Shailbala Singh; Haroldo Toro; De-Chu Tang; Worthie E Briles; Linda M Yates; Renee T Kopulos; Ellen W Collisson
Journal:  Virology       Date:  2010-06-16       Impact factor: 3.616

2.  Mucosal, Cellular, and Humoral Immune Responses Induced by Different Live Infectious Bronchitis Virus Vaccination Regimes and Protection Conferred against Infectious Bronchitis Virus Q1 Strain.

Authors:  Rajesh Chhabra; Anne Forrester; Stephane Lemiere; Faez Awad; Julian Chantrey; Kannan Ganapathy
Journal:  Clin Vaccine Immunol       Date:  2015-07-22

3.  Adoptive transfer of infectious bronchitis virus primed alphabeta T cells bearing CD8 antigen protects chicks from acute infection.

Authors:  S H Seo; J Pei; W E Briles; J Dzielawa; E W Collisson
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

4.  Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands.

Authors:  G Bijlenga
Journal:  J Infect       Date:  2005-07-19       Impact factor: 6.072

5.  Oral immunization with a novel attenuated Salmonella Gallinarum encoding infectious bronchitis virus spike protein induces protective immune responses against fowl typhoid and infectious bronchitis in chickens.

Authors:  Irshad Ahmed Hajam; Jehyoung Kim; John Hwa Lee
Journal:  Vet Res       Date:  2018-09-12       Impact factor: 3.683

6.  SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.

Authors:  C Sylvester-Hvid; M Nielsen; K Lamberth; G Røder; S Justesen; C Lundegaard; P Worning; H Thomadsen; O Lund; S Brunak; S Buus
Journal:  Tissue Antigens       Date:  2004-05

Review 7.  How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past.

Authors:  Anne S De Groot
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.